V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006662 | 320004086 | 1.85 | 56.35 | Palliative (P) | 2016-10-21 | 2016-12-02 | TEMOZOLOMIDE | N | N | 320025218 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006663 | 320004090 | 1.57 | 64.8 | Palliative (P) | 2015-04-27 | 2015-05-10 | ETOPOSIDE | 02 | N | 320000073 | IMATINIB |
| 320006664 | 320004092 | 1.77 | 71.2 | Curative (C) | 2015-03-28 | 2016-03-18 | Cyclophosphamide PO +Vinorelbine IV | N | N | 320001140 | TEMOZOLOMIDE |
| 320006665 | 320004094 | 1.62 | 63.3 | Palliative (P) | null | 2017-06-18 | POMALIDOMIDE | 02 | N | 320001462 | CAV |
| 320006666 | 320004095 | 1.78 | null | Palliative (P) | 2017-04-08 | 2017-04-21 | Cisplatin + Etoposide (3 day) | N | N | 320002399 | MITOMYCIN INTRAVESICULAR |
| 320006667 | 320004095 | 1.74 | 81.1 | Palliative (P) | 2017-12-03 | 2018-12-17 | EW EuroEwing 99 : VActC | 2 | N | 320002399 | CARBOPLATIN + CETUXIMAB + FU |
| 320006668 | 320005877 | null | 87.5 | Curative (C) | 2014-04-20 | 2016-11-27 | Ifosfamide | N | null | 320003697 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006669 | 320004100 | 1.83 | 72 | Palliative (P) | null | 2018-02-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320003787 | ECX |
| 320006670 | 320004101 | 1.53 | 66.2 | Not known (9) | 2018-07-11 | 2018-07-24 | Abiraterone | N | N | 320003872 | GEMCITABINE |
| 320006671 | 320004103 | 1.6 | 50.4 | Palliative (P) | 2015-05-20 | 2015-09-13 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320004095 | DOCETAXEL + GEMCITABINE |
| 320006672 | 320004106 | null | 57.4 | Adjuvant (A) | 2016-05-30 | 2016-10-25 | ICON8B TRIAL | N | N | 320004762 | VINCRISTINE |
| 320006673 | 320004108 | 1.76 | null | Neo-adjuvant (N) | null | 2016-08-10 | PEMBROLIZUMAB | N | N | 320004866 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320006674 | 320004111 | 1.72 | 61 | Curative (C) | 2013-11-29 | 2014-01-24 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320004917 | CARBOPLATIN + CETUXIMAB + FU |
| 320006675 | 320004119 | null | 74.4 | Curative (C) | null | 2017-09-07 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 320007716 | CARBOPLATIN + PEMETREXED |
| 320006676 | 320006725 | null | 78.5 | Palliative (P) | 2015-08-11 | 2015-10-07 | PEMBROLIZUMAB | 02 | N | 320007731 | ECX |
| 320006677 | 320004121 | null | 90.3 | Palliative (P) | 2014-06-11 | 2014-07-03 | Docetaxel 75mg/m2 (21 day) | Y | N | 320007895 | CAPECITABINE + CARBOPLATIN |
| 320006678 | 320004121 | 1.59 | 65.4 | Palliative (P) | 2017-12-08 | 2018-03-03 | Ipilimumab | N | N | 320007895 | TOPOTECAN |
| 320006679 | 320004124 | 1.55 | 54.1 | Adjuvant (A) | 2015-06-01 | 2015-06-05 | CARBOPLATIN + RT | 01 | N | 320007902 | ICON TRIAL |
| 320006680 | 320004126 | 1.48 | 60 | Palliative (P) | null | 2017-01-03 | PAC-E | 02 | N | 320008270 | CISPLATIN + LIPOSOMAL DOXORUBICIN |
| 320006681 | 320004128 | 1.6 | 37.55 | Curative (C) | 2016-05-16 | 2016-04-22 | Carbo F | null | null | 320008313 | CAPECITABINE + CARBOPLATIN |
| 320006682 | 320004129 | 1.84 | 77.4 | Palliative (P) | 2015-02-04 | 2015-02-04 | CAP | 02 | N | 320008315 | DOXORUBICIN |
| 320006683 | 320004133 | null | 69 | Palliative (P) | 2018-02-01 | 2018-04-28 | CYCLOPHOSPHAMIDE | N | N | 320008581 | BEVACIZUMAB + CARBO |
| 320006684 | 320004136 | 1.65 | 75.2 | Palliative (P) | 2017-08-16 | 2017-08-19 | EW EuroEwing 99 : VActC | Y | N | 320008611 | CISPLATIN + GEMCITABINE |
| 320006685 | 320004137 | 1.66 | 60.9 | Palliative (P) | 2017-03-16 | 2017-03-16 | Gemcitabine + Treosulfan (iv) | 02 | N | 320008714 | IRINOTECAN + MDG |
| 320006686 | 320004141 | 1.68 | 57.6 | Palliative (P) | 2016-05-17 | 2016-10-18 | Ipilimumab | Y | null | 320008755 | VEMURAFENIB |
| 320006687 | 320004145 | 1.62 | 72.8 | Neo-adjuvant (N) | 2017-02-23 | 2017-07-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320008864 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320006688 | 320004147 | 1.75 | null | Palliative (P) | 2016-09-01 | 2016-09-14 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 320008875 | ETOPOSIDE + IFOSFAMIDE |
| 320006689 | 320004149 | 1.55 | 65.5 | Palliative (P) | 2018-01-14 | 2018-01-15 | Irinotecan + Modified De Gramont | N | N | 320008881 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320006690 | 320004151 | 1.62 | 64 | Palliative (P) | 2017-11-08 | 2017-12-01 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320009166 | IRINOTECAN + MDG |
| 320006691 | 320004153 | 1.59 | 59.3 | Palliative (P) | 2017-01-31 | 2017-02-01 | Capecitabine (14 days)+Carboplatin | N | N | 320009201 | IRINOTECAN + VINCRISTINE |
| 320006692 | 320004155 | 1.53 | 39.8 | Palliative (P) | 2019-02-23 | 2019-02-24 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 320009451 | GEMCITABINE |
| 320006693 | 320004155 | null | 46 | Palliative (P) | 2018-08-25 | 2018-11-06 | Capecitabine | null | null | 320009451 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006694 | 320005905 | 1.62 | 51.7 | Palliative (P) | 2016-12-18 | 2016-12-18 | REGORAFENIB | N | N | 320009502 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320006695 | 320004161 | 1.68 | 61.4 | Palliative (P) | 2014-10-28 | 2014-11-26 | Cetuximab + Radiotherapy Maint | N | N | 320009627 | CETUXIMAB + RT |
| 320006696 | 320005908 | null | 63.6 | Palliative (P) | 2016-09-28 | 2016-09-28 | Docetaxel 75mg/m2 (21 day) | Y | N | 320009740 | CAPECITABINE + OXALIPLATIN |
| 320006697 | 320004163 | 1.6 | 74.6 | Curative (C) | 2015-03-06 | 2015-03-21 | Bevacizumab + Cape + Oxali 21day | N | null | 320009996 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320006698 | 320004165 | 1.6 | 42 | Palliative (P) | 2015-01-27 | 2015-02-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 320010593 | CARBOPLATIN + ETOPOSIDE |
| 320006699 | 320007133 | 1.73 | 80 | null | 2017-05-02 | 2017-05-10 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 320011018 | EOX |
| 320006700 | 320004166 | null | 108.6 | Palliative (P) | 2016-03-26 | 2016-04-21 | Cyclophosphamide oral | N | N | 320011028 | CTW |
| 320006701 | 320005914 | 1.65 | 74.5 | Palliative (P) | 2018-06-01 | 2018-06-02 | Capecitabine | Y | N | 320011625 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006702 | 320004171 | 1.69 | 67.8 | Palliative (P) | 2016-10-10 | 2016-10-28 | Imatinib 400mg | N | N | 320011851 | CISPLATIN + LIPOSOMAL DOXORUBICIN |
| 320006703 | 320004172 | 1.69 | 57.1 | Palliative (P) | 2018-05-09 | 2018-05-12 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320011994 | NIVOLUMAB |
| 320006704 | 320004175 | 1.6 | null | Neo-adjuvant (N) | 2016-12-25 | 2017-01-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320012126 | CISPLATIN + LIPOSOMAL DOXORUBICIN |
| 320006705 | 320004176 | 1.77 | 66.1 | Curative (C) | 2017-04-05 | 2017-04-09 | IMATINIB | Y | null | 320012129 | CISPLATIN + GEMCITABINE |
| 320006706 | 320004177 | 1.73 | 0 | Palliative (P) | 2016-11-07 | 2017-08-04 | GEMCITABINE | 02 | N | 320012147 | CARBOPLATIN + RT |
| 320006707 | 320004179 | 1.89 | 74 | Neo-adjuvant (N) | 2019-05-15 | 2019-05-23 | Cetuximab + Radiotherapy Maint | N | N | 320012188 | CARBO + FLUOROURACIL |
| 320006708 | 320004182 | null | null | Palliative (P) | 2018-01-10 | 2018-01-20 | Bevacizumab+Carbo+Pacliaxel | N | N | 320012197 | PEMBROLIZUMAB |
| 320006709 | 320004190 | 1.8 | 73.8 | Palliative (P) | 2015-09-07 | 2015-09-10 | Y-90 | N | N | 320012878 | PEMBROLIZUMAB |
| 320006710 | 320004190 | 1.73 | 105 | Palliative (P) | 2014-10-12 | 2016-03-30 | Carboplatin + Etoposide IV 3 day | 02 | N | 320012878 | BCG |
| 320006711 | 320004193 | 1.73 | 61.9 | Palliative (P) | 2018-12-02 | 2018-12-02 | Cyclophosphamide PO +Vinorelbine IV | 02 | null | 320013012 | OCTOPUS TRIAL |